Sign up to save your podcasts
Or
Share Episode 452: ESMO 2025 - DV+ toripalimab in bladder cancer
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Episode 452: ESMO 2025 - DV+ toripalimab in bladder cancer
Matt Galsky discusses the exciting Presidential session data from the Chinese phase 3 of DV+ toripalimab in advanced urothelial cancer.
View all episodes
By The Uromigos
4.9
5757 ratings
Matt Galsky discusses the exciting Presidential session data from the Chinese phase 3 of DV+ toripalimab in advanced urothelial cancer.
More shows like The Uromigos
View all
TED Radio Hour
21,948 Listeners
Freakonomics Radio
32,249 Listeners
Planet Money
30,707 Listeners
JAMA Clinical Reviews
500 Listeners
Behind The Knife: The Surgery Podcast
1,306 Listeners
Prostate Cancer Update
16 Listeners
ASCO Daily News
59 Listeners
The Diary Of A CEO with Steven Bartlett
8,826 Listeners
OncLive® On Air
23 Listeners
GU Cast | Urology Podcast
2 Listeners
Oncology Today with Dr Neil Love
60 Listeners
People I (Mostly) Admire
2,052 Listeners
ZOE Science & Nutrition
2,155 Listeners
Two Onc Docs
196 Listeners
Oncology Brothers: Practice-Changing Cancer Discussions
46 Listeners